All In MedTech

FDA Clearance Tracker · P230009-S010

Shield

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 22, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P230009-S010
Device name
Shield
Applicant location
Palo Alto, CA
Received
Nov 14, 2025
Decided
Jul 22, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P230009

Device type

Device class
Class III

Every decision under product code PHP

FDA's approval statement

As written in FDA's record.

Approval for a change to the Shield EP1 classification model which streamlines Guardant Shield to a methylation-only workflow, removing fragmentomic and somatic components.

Source documents

Other decisions for Guardant Health, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.